Document Title
Letter to the House Committee on Oversight and Reform: Hearing on Examining the Actions of Drug Companies in Raising Prescription Drug Prices
Synopsis
ACP sends a letter to the House Committee on Oversight and Reform on its hearing on examining the actions of drug companies in raising prescription drug prices.
Keywords
prescription drug cost, drug prices, generic drugs, Chairman Cummings, Ranking Member Jordan, CREATES Act, improve competition, product-hopping, ever greening, pay for delay, generic drugs, transparency, reimportation, Medicare, drug formularies
Creation Date
Modified Date
Pages
8
Document
acp_letter_to_house_oversight_hearing_on_prescription_drugs_2019.pdf
Adobe Metadata
{"CreationDate":"2019-02-12T10:17:36-05:00","Creator":"Microsoft\u00ae Word 2016","Keywords":"prescription drug cost, drug prices, generic drugs, Chairman Cummings, Ranking Member Jordan, CREATES Act, improve competition, product-hopping, ever greening, pay for delay, generic drugs, transparency, reimportation, Medicare, drug formularies","ModDate":"2019-02-12T10:26:21-05:00","Producer":"Microsoft\u00ae Word 2016","Title":"Letter to the House Committee on Oversight and Reform: Hearing on Examining the Actions of Drug Companies in Raising Prescription Drug Prices","Pages":8,"dc:format":"application\/pdf","dc:creator":"","dc:title":"Letter to the House Committee on Oversight and Reform: Hearing on Examining the Actions of Drug Companies in Raising Prescription Drug Prices","dc:subject":["prescription drug cost","drug prices","generic drugs","Chairman Cummings","Ranking Member Jordan","CREATES Act","improve competition","product-hopping","ever greening","pay for delay","generic drugs","transparency","reimportation","Medicare","drug formularies"],"xmp:createdate":"2019-02-12T10:17:36-05:00","xmp:creatortool":"Microsoft\u00ae Word 2016","xmp:modifydate":"2019-02-12T10:26:21-05:00","xmp:metadatadate":"2019-02-12T10:26:21-05:00","pdf:producer":"Microsoft\u00ae Word 2016","pdf:keywords":"prescription drug cost, drug prices, generic drugs, Chairman Cummings, Ranking Member Jordan, CREATES Act, improve competition, product-hopping, ever greening, pay for delay, generic drugs, transparency, reimportation, Medicare, drug formularies","xmpmm:documentid":"uuid:b0eec35b-4531-441e-8355-de391fcb9af7","xmpmm:instanceid":"uuid:a3d6ce1f-bc69-4c4d-8efd-b594b5649ede"}
Document Type
Letter
Year
2019